Skip to Main Content

Paper Details

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C19 and Proton Pump Inhibitor Dosing.
Clin Pharmacol Ther
132
2021
Author NameAffiliation
Sara L Van DriestVanderbilt University School of Medicine
Nihal El RoubyDepartment of Pharmacotherapy and Translational Research, and Center for Pharmacogenomics and Precision Medicine, University of Florida
Nihal El RoubyDivision of Pharmacy Practice & Administrative Sciences, University of Cincinnati James Winkle College of Pharmacy
Julie A JohnsonDepartment of Pharmacotherapy and Translational Research, and Center for Pharmacogenomics and Precision Medicine, University of Florida
Larisa H CavallariDepartment of Pharmacotherapy and Translational Research, and Center for Pharmacogenomics and Precision Medicine, University of Florida
Stuart A ScottIcahn School of Medicine at Mount Sinai
Stuart A Scott
Matthias Schwab
Matthias SchwabUniversity Hospital
Matthias SchwabDepartment of Pharmacy and Biochemistry, University of Tuebingen
Teri E KleinStanford University
  • 1 - 11

Datasets